Abstract: Disclosed is an air conditioner including a housing having a suction port and a discharge port, a discharge panel having a plurality of discharge holes and disposed at the discharge port, a blowing fan provided inside the housing, and a reinforcing member disposed at a rear of the discharge panel to support the discharge panel. With this configuration, it is possible to prevent the discharge panel from being deformed by pressing, and to minimize the exposure of the inside of the air conditioner through the discharge hole of the discharge panel.

Abstract: The present invention provides intermediates useful for the synthesis of an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors; and processes for preparing the same. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.

Abstract: An organic light emitting diode including a first electrode; a second electrode facing the first electrode; and an emitting material layer including a first compound and a second compound and positioned between the first and second electrodes. An energy level of the first compound and an energy level of the second compound satisfy a pre-determined condition. An organic light emitting device may include the organic light emitting diode.

Abstract: The present disclosure relates to an organic light emitting diode (OLED) including plural light emitting material layers disposed between two electrodes and an electron blocking layer, wherein an energy level of the electron blocking layer disposed adjacently to an emitting material layer with relatively low level delayed fluorescent material and an energy level of the delayed fluorescent material are controlled, and an organic light emitting device having the diode. The OLED can lower its driving voltage and maximize its luminous efficiency and luminous lifetime.

Abstract: An organic light emitting diode (OLED) including at least one emitting material layer (EML) disposed two electrodes and comprising triazine-based delayed fluorescent material and boron-dipyrromethene-based fluorescent material and an organic light emitting device including the OLED is disclosed. The triazine-based delayed fluorescent material and the boron-dipyrromethene-based fluorescent material may be included in an identical EML or in adjacently disposed EMLs. The OLED can lower its driving voltage and improve its luminous efficiency by adjusting energy levels of the delayed fluorescent material and the fluorescent material.

Abstract: The present disclosure relates to an organic light emitting diode and an organic light emitting device having the diode. An organic light emitting diode including a plurality delayed fluorescent materials with specific energy levels and an organic light emitting device including the diode is disclosed. When the plurality delayed fluorescent materials with specific energy levels are applied in an emitting material layer, it is possible to minimize the energy loss or exciton quenching during luminescent process, to prevent the diode from reducing lifetime caused by the exciton quenching, and to make charges being injected into the emitting material layer in balance. When the emitting material layer includes other luminous material having a narrow FWHM, the organic light emitting diode can enhance its color purity.

Abstract: An air conditioner includes a housing having first and second suction ports; a heat exchanger configured to exchange heat with air brought in through the first suction port; a first discharging port configured to discharge the heat-exchanged air; a second discharging port configured to discharge air brought in through the second suction port to be mixed with air discharged from the first discharging port at outside of the housing; a discharging door having a plurality of discharging holes, through which air directed to the first discharging port is discharged out of the housing, and selectively opening the second discharging port by movement operation of the discharging door.

Abstract: Provided is an in-vitro diagnostic apparatus having a cartridge. The cartridge includes a body to which a biochip is detachably coupled, and the body includes a plurality of sample accommodating chambers. The disc member includes a cylinder portion and a sample mixing chamber, wherein the cylinder portion has a hollow tube form and is coupled to the body, and the sample mixing chamber is disposed under the cylinder portion. A fluid input/output port is provided in a bottom portion of each of the sample accommodating chambers. The sample mixing chamber includes a fluid path and an injection path, the fluid path selectively connectable to the fluid input/output port, and the injection path connecting the sample mixing chambers with the biochip. A syringe piston is coupled to the cylinder portion and configured to slidably elevate along the cylinder portion.

Abstract: The present disclosure relates to an organic compound having the following structure, and an organic light emitting diode (OLED) and an organic light emitting device including the organic compound. The organic compound is a bipolar compound having a p-type moiety and an n-type moiety and has high energy level and proper energy bandgap for an emissive layer of the OLED. As the organic compound is applied into the emissive layer, the OLED can maximize its luminous properties as holes and electrons are recombined uniformly over the whole area in an emitting material layer (EML).

Abstract: The present invention provides a novel process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.

Abstract: An air conditioner includes a housing having a first inlet port and a second inlet port, a first discharge port, a second discharge port, the air discharged through the second discharge port is mixed with the air discharged through the first discharge port, and having a plurality of discharge holes to cause the air discharged from the first discharge port to be discharged more slowly than air discharged from the second discharge port, a heat exchanger configured to heat-exchange the air entered through the first inlet port, a first fan arranged to draw the air into the housing through the first inlet port, and to discharge the air from the housing through the first discharge port, and a second fan arranged to draw the air into the housing through the second inlet port, and to discharge the air from the housing through the second discharge port.

Abstract: Provided is a pharmaceutical composition for oral administration, including (a) a taxane, (b) a medium chain triglyceride, (c) an oleoyl glycerol complex having 30 to 65% by weight of monooleoyl glycerol contents; 15 to 50% by weight of dioleoyl glycerol contents; and 2 to 20% by weight of trioleoyl glycerol contents, (d) a surfactant, and optionally (e) polyoxyl glyceryl fatty acid ester and a process for preparing the same.

Abstract: An air conditioner includes a housing having a blowing port, a first guide configured to cover a portion of the blowing port, a second guide configured to cover another portion of the blowing port, a motor configured to rotate the first guide and the second guide, a first gear configured to be connected to the first guide, a guide holder configured to be connected to the second guide, and a second gear configured to connect the first gear to the motor.

Abstract: The present invention provides a novel process for preparing an aminopyrimidine derivative or pharmaceutically acceptable salt thereof having a selective inhibitory activity against protein kinases, especially against the protein kinases for mutant epidermal growth factor receptors. And also, the present invention provides novel intermediates useful for said process and processes for preparing the same.

Abstract: Disclosed herein are a vehicle control apparatus and a method for controlling a vehicle using the same. The vehicle control apparatus according to an embodiment of the present invention includes an input unit that receives handle operation information detected by a sensing device, receives avoidance steering information of a driver, and receives behavior information of a vehicle, a determination unit that determines whether the vehicle is in an emergency steering avoidance state based on the received handle operation information, the received avoidance steering information of the driver, and the received behavior information of the vehicle, and a control unit that controls an evasive handling control (EHC) system and an electronic stability control (ESC) system such that the EHC system presses wheels in advance ahead of the ESC system to perform a braking operation according to a target wheel pressure value, when the vehicle is in the emergency steering avoidance state.

Abstract: Provided is a pharmaceutical composition for oral administration, including (a) a taxane, (b) a medium chain triglyceride, (c) an oleoyl glycerol complex having 30 to 65% by weight of monooleoyl glycerol contents; 15 to 50% by weight of dioleoyl glycerol contents; and 2 to 20% by weight of trioleoyl glycerol contents, (d) a surfactant, and optionally (e) polyoxyl glyceryl fatty acid ester and a process for preparing the same.

Abstract: The present invention relates to a heart targeting agent comprising tannic acid, in which the agent aids a heart disease therapeutic drug to be delivered to the heart and bind to the cardiac myocardium by inducing tannylation of the drug so as to make heart targeting and accumulation of the drug possible. Unlike the conventional invasive method used for the traditional drugs to be able to target the heart, the agent of the present invention can help a drug to target the heart with high efficiency just via non-invasive intravenous administration.

Abstract: Provided is an air conditioner including a housing, a suction port disposed in the housing, a first discharge port disposed in the housing to discharge a part of air sucked through the suction port, and a second discharge port disposed in the housing to discharge other part of air sucked through the suction port, a heat exchanger configured to perform heat-exchange on the part of air sucked through the suction port, a first blowing fan configured to suck the part of air, which is sucked through the suction port, to discharge the sucked air to the first discharge port, and an intermediate member configured to guide the part of air sucked through the suction port to the heat exchanger, and configured to separate other part of air s sucked through the suction port from the part of air sucked through the suction port.

Abstract: An air conditioner includes a heat exchanger for exchanging heat with air introduced to an inside of a housing and a fan for blowing the air having heat exchanged by the heat exchanger to an outside of the housing, the air conditioner capable of blowing air at various airflows by controlling a door configured to selectively open a first portion and a second portion, different from the first portion, of an air outlet of the housing and controlling a guide member configured to controlling a flow path inside the housing.

Abstract: A thermoplastic resin composition of the present invention comprises: (A) 100 parts by weight of a thermoplastic resin comprising (A1) a rubber-modified aromatic vinyl-based graft copolymer, (A2) an aromatic vinyl-based copolymer resin having a flow index of about 5 g/10 min to about 8 g/10 min as measured by the ASTM D 1238 standard, and (A3) an ?-methylstyrene copolymer; and (B) about 0.1 to about 10 parts by weight of zinc oxide, wherein the zinc oxide has a size ratio (B/A) of peak A in the region of 370 nm to 390 nm to peak B in the region of 450 nm to 600 nm of about 0.01 to about 1 in photoluminescence measurement, and has a BET surface area of about 10 m2/g or less as measured by a BET analyzer.